MUSC Hollings Cancer Center

Lipid Signaling in Cancer

Program Leader
Besim Ogretmen, PhD

Lipid Signaling in Cancer Members

The scientific focus of the Lipid Signaling in Cancer (LSC) research program is to develop a sophisticated understanding of critical and novel lipid-mediated signaling pathways in oncogenesis and stress responses that will enable the elucidation of cancer pathogenesis and mechanisms of therapeutics. 

This cutting edge research into novel pathways sets the stage for the development of unique molecules that modify these signaling pathways and can serve as conceptual and practical tools in translational therapeutic development. Thus, the specific scientific themes are focused on defining the role of bioactive lipids in cancer biology and defining the role of specific enzymes of lipid metabolism as novel targets for cancer prevention and therapy.

>> Lipid Signaling in Cancer Program Retreat Information

To find out more about this research program, e-mail program leader, Besim Ogretmen, PhD at


* This website is best viewed in Firefox or Chrome internet browsers.